A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/20 (2006.01) A23L 1/30 (2006.01) A61K 31/00 (2006.01) A61K 31/045 (2006.01) A61K 31/16 (2006.01) A61K 31/201 (2006.01) A61K 31/23 (2006.01) A61P 3/00 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2353805
This invention relates to a novel method for the treatment and / or prevention of preferably non-insulin dependent (NIDDM or so-called Type II) diabetes mellitus, or other conditions associated with impaired glucose tolerance such as obesity, and in particular to the use of phytanic acid derivatives for the said treatment and / or prevention.
Cette invention concerne un nouveau procédé de traitement et/ou de prévention du diabète, de préférence, non insulinodépendant (DNID ou diabète de type II) ou d'autres conditions associées à l'intolérance au glucose, comme l'obésité, et en particulier l'utilisation de dérivés d'acide phytanique pour ledit traitement et/ou ladite prévention.
Fluehmann Beat
Heim Manuel
Hunziker Willi
Weber Peter
Dsm Ip Assets B.v.
Roche Vitamins Ag
Smart & Biggar
LandOfFree
Use of phytanic acid for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of phytanic acid for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of phytanic acid for the treatment of diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1548291